Here, we show that IRF5 and CD11c expression is linked to symptomatic and vulnerable carotid plaques in humans, and that IRF5 drives pro-inflammatory CD11c+ macrophages and inducible plaque rupture in ApoE−/− mice, demonstrating IRF5 as a candidate therapeutic target in human atherosclerosis. The gene discussed is IRF5; the disease is atherosclerosis.